PAIGE
PrivateLast Round
M&A
Aug 22, 2025
Total Funding Raised
$220M
Momentum
Quiet
No recent growth signals
Company Overview
Paige is a healthcare technology company that offers a computational pathology platform for rapid diagnostic stratification and cancer detection using advanced deep learning algorithms.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Precision Medicine, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Data as a Service, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PAIGE Comps
Public and private peers based on sector, stage, and business model.
PAIGE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Aug 22, 2025 | ||||
| Series C Extension | Mar 9, 2021 | ||||
| Series C | Jan 14, 2021 | ||||
| Series B Extension | Jul 13, 2020 | ||||
| Series B Extension | Apr 23, 2020 | ||||
Series B | Dec 18, 2019 |
PAIGE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Series B, Series A |
| Kohlberg Kravis Roberts | Series C Extension |
| HealthCare Ventures | Series B Extension, Series B |
| Catalio Capital Management | Series C Extension |
| Goldman Sachs Group, Inc. | Series B Extension |
| Casdin Capital | Series C Extension, Series C |
| Healthcare Venture Partners | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2025
Announced PRISM2, its most advanced slide-level foundation model.
- Jun 12, 2025
Partnered with Breast International Group for breast cancer research.
PAIGE Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PAIGE's valuation, stock price, and market status.